Hunterbrook goes long Hims & Hers after short position in June
After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...
Hims & Hers surges: Analysts say it's well-positioned under Trump
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
Kohl's CEO to depart after less than two years at the helm
Since Kingsbury was named as interim CEO in December 2022, Kohl's shares have lost more than 40%. The company, which is ...
Yahoo13h
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops
Cassava Sciences stock plummeted Monday after the company's Alzheimer's treatment failed in Phase 3 testing. Billionaire Ken ...
Business Insider22h
BofA says FDA head nominee positive development for compounders like Hims & Hers
BofA notes that Dr. Martin Makary, the man who President-elect Donald Trump nominated to lead the Food and Drug Administration as its commissioner, is the Chief Medical Officer for Sesame, a ...